SCM
SOPH icon

Soleus Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Soleus Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.03M Sell
1,565,000
-285,000
-15% -$1.45M 0.31% 59
2026
Q1 		$9.16M Buy
+1,850,000
New +$9M 0.37% 54

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return

Soleus Capital Management's SOPH Position: Q2 2026 in Review

Soleus Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 15% in Q2 2026, selling an estimated $1.45M and leaving 1,565,000 shares worth $9.03M. The position accounts for 0.31% of the portfolio, ranked #59.

Soleus Capital Management first reported a position in SOPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.16M in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Soleus Capital Management held 1,565,000 shares of SOPHiA GENETICS worth $9.03M as of Q2 2026.
  • Soleus Capital Management sold 285,000 SOPHiA GENETICS shares in Q2 2026, an estimated $1.45M.
  • SOPHiA GENETICS made up 0.31% of Soleus Capital Management's portfolio in Q2 2026, its #59 holding.
  • Soleus Capital Management first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 2 quarters since.
  • Soleus Capital Management's SOPHiA GENETICS position peaked at $9.16M in Q1 2026.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.